Jpmorgan Chase & CO Stoke Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 15,452 shares of STOK stock, worth $144,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,452
Previous 15,253 1.3%
Holding current value
$144,630
Previous $206,000 8.25%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$12.24 - $15.92 $2,435 - $3,168
199 Added 1.3%
15,452 $189,000
Q3 2024

Nov 08, 2024
BUY
$12.24 - $15.92 $2,435 - $3,168
199 Added 1.3%
15,452 $189,000
Q2 2024

Dec 26, 2024
SELL
$11.03 - $17.52 $2,194 - $3,486
-199 Reduced 1.29%
15,253 $206,000
Q2 2024

Aug 12, 2024
BUY
$11.03 - $17.52 $47,528 - $75,493
4,309 Added 39.37%
15,253 $206,000
Q1 2024

Dec 26, 2024
SELL
$4.12 - $14.17 $18,572 - $63,878
-4,508 Reduced 29.17%
10,944 $147,000
Q1 2024

May 10, 2024
SELL
$4.12 - $14.17 $29,618 - $101,868
-7,189 Reduced 39.65%
10,944 $147,000
Q4 2023

Dec 26, 2024
BUY
$3.37 - $5.4 $9,034 - $14,477
2,681 Added 17.35%
18,133 $95,000
Q4 2023

Feb 12, 2024
SELL
$3.37 - $5.4 $28,297 - $45,343
-8,397 Reduced 31.65%
18,133 $95,000
Q3 2023

Nov 14, 2023
BUY
$3.78 - $11.99 $12,712 - $40,322
3,363 Added 14.52%
26,530 $104,000
Q2 2023

Aug 11, 2023
SELL
$7.93 - $13.82 $724,009 - $1.26 Million
-91,300 Reduced 79.76%
23,167 $246,000
Q1 2023

May 18, 2023
BUY
$7.65 - $10.38 $215,271 - $292,093
28,140 Added 32.6%
114,467 $953,000
Q1 2023

May 11, 2023
BUY
$7.65 - $10.38 $477,880 - $648,417
62,468 Added 261.82%
86,327 $719,000
Q4 2022

Feb 13, 2023
BUY
$7.07 - $15.69 $2,057 - $4,565
291 Added 1.23%
23,859 $220,000
Q3 2022

Nov 14, 2022
BUY
$12.56 - $22.53 $13,439 - $24,107
1,070 Added 4.76%
23,568 $302,000
Q2 2022

Aug 11, 2022
BUY
$10.36 - $23.93 $29,940 - $69,157
2,890 Added 14.74%
22,498 $297,000
Q1 2022

May 11, 2022
BUY
$17.19 - $26.1 $57,999 - $88,061
3,374 Added 20.78%
19,608 $412,000
Q4 2021

Feb 10, 2022
BUY
$18.11 - $30.72 $27,273 - $46,264
1,506 Added 10.23%
16,234 $390,000
Q3 2021

Nov 12, 2021
BUY
$23.65 - $34.44 $348,317 - $507,232
14,728 New
14,728 $375,000

Others Institutions Holding STOK

# of Institutions
125
Shares Held
57.6M
Call Options Held
9.3K
Put Options Held
35.2K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $369M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email